Screener
LeMaitre Vascular LMAT CA — Revenue (Gross)
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Net sales | $70,382 | $64,232 | $136,933 | $124,103 |
| Cost of sales | 19,618 | 19,258 | 37,773 | 37,709 |
| Gross profit | 50,764 | 44,974 | 99,160 | 86,394 |
| Sales and marketing | 14,408 | 14,895 | 28,923 | 29,107 |
| General and administrative | 11,110 | 10,396 | 23,156 | 20,883 |
| Research and development | 4,847 | 3,541 | 8,907 | 7,636 |
| Total operating expenses | 30,365 | 28,832 | 60,986 | 57,626 |
| Income from operations | 20,399 | 16,142 | 38,174 | 28,768 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's CA — revenue (gross)?
- LeMaitre Vascular (LMAT) reported CA — revenue (gross) of $4.55M in Q2 2026.
- How has LeMaitre Vascular's CA — revenue (gross) changed year-over-year?
- LeMaitre Vascular's CA — revenue (gross) increased by 15.1% year-over-year, from $3.96M to $4.55M.
- What is the long-term trend for LeMaitre Vascular's CA — revenue (gross)?
- Over 3 years (2022 to 2025), LeMaitre Vascular's CA — revenue (gross) has grown at a 22.3% compound annual growth rate (CAGR), from $8.34M to $15.25M.
- What does CA — revenue (gross) mean?
- This metric represents the total gross revenue generated from sales of medical devices within the specified geographic segment, inclusive of any assessed taxes. It serves as a key indicator of the company's market penetration and commercial success within this specific region. Tracking this figure allows investors to evaluate the growth trajectory and regional demand for the company's vascular surgical product portfolio.
Ask your AI about LeMaitre Vascular's ca — revenue (gross).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude